Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 1;321(1):E156-E163.
doi: 10.1152/ajpendo.00642.2020. Epub 2021 May 31.

Insulin action in the brain regulates both central and peripheral functions

Affiliations
Review

Insulin action in the brain regulates both central and peripheral functions

Rahul Agrawal et al. Am J Physiol Endocrinol Metab. .

Abstract

The brain has been traditionally thought to be insensitive to insulin, primarily because insulin does not stimulate glucose uptake/metabolism in the brain (as it does in classic insulin-sensitive tissues such as muscle, liver, and fat). However, over the past 20 years, research in this field has identified unique actions of insulin in the brain. There is accumulating evidence that insulin crosses into the brain and regulates central nervous system functions such as feeding, depression, and cognitive behavior. In addition, insulin acts in the brain to regulate systemic functions such as hepatic glucose production, lipolysis, lipogenesis, reproductive competence, and the sympathoadrenal response to hypoglycemia. Decrements in brain insulin action (or brain insulin resistance) can be observed in obesity, type 2 diabetes (T2DM), aging, and Alzheimer's disease (AD), indicating a possible link between metabolic and cognitive health. Here, we describe recent findings on the pleiotropic actions of insulin in the brain and highlight the precise sites, specific neuronal population, and roles for supportive astrocytic cells through which insulin acts in the brain. In addition, we also discuss how boosting brain insulin action could be a therapeutic option for people at an increased risk of developing metabolic and cognitive diseases such as AD and T2DM. Overall, this perspective article serves to highlight some of these key scientific findings, identify unresolved issues, and indicate future directions of research in this field that would serve to improve the lives of people with metabolic and cognitive dysfunctions.

Keywords: brain; diabetes; hypoglycemia; hypothalamus; insulin.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest, financial or otherwise, are declared by the authors.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
In addition to regulating CNS (via neurons and/or astrocytes) functions (such as cognition, depression, and food intake), insulin acts in the brain to regulate peripheral functions via the autonomic nervous system (ANS) and the hypothalamic pituitary axis (HPA). Specifically, insulin acts in the prefrontal cortex and hippocampus to improve cognitive function and reduce depressive symptoms. Insulin acts in the hypothalamic nuclei to decrease food intake and reduce body weight. Via the efferent autonomic nervous system to target organs, insulin acts in the brain to decrease hepatic glucose production, increase lipogenesis, decrease lipolysis, and increase the sympathoadrenal response to hypoglycemia. Insulin acts via the hypothalamic-pituitary-gonadal axis to improve reproductive competence. CNS, central nervous system.

References

    1. Banks WA, Kastin AJ. Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19: 883–889, 1998. doi:10.1016/s0196-9781(98)00018-7. - DOI - PubMed
    1. Gray SM, Barrett EJ. Insulin transport into the brain. Am J Physiol Cell Physiol 315: C125–C136, 2018. doi:10.1152/ajpcell.00240.2017. - DOI - PMC - PubMed
    1. Haddad-Tovolli R, Dragano NRV, Ramalho AFS, Velloso LA. Development and function of the blood-brain barrier in the context of metabolic control. Front Neurosci 11: 224, 2017. doi:10.3389/fnins.2017.00224. - DOI - PMC - PubMed
    1. Banks W. The blood-brain barrier interface in diabetes mellitus: dysfunctions, mechanisms and approaches to treatment. Curr Pharm Design 26: 1438–1447, 2020. doi:10.2174/1381612826666200325110014. - DOI - PubMed
    1. Sun YN, Liu LB, Xue YX, Wang P. Effects of insulin combined with idebenone on blood-brain barrier permeability in diabetic rats. J Neurosci Res 93: 666–677, 2015. doi:10.1002/jnr.23511. - DOI - PubMed

Publication types

LinkOut - more resources